Citalopram-induced generalized lipidosis in rats.

This study was focussed on the question of whether or not the potential antidepressant citalopram, which is an amphiphilic cationic compound, can induce generalized lipidosis in animals. In a short term experiment, female rats were treated with a single oral dose (100 mg/kg) and the lymph node was examined by electron microscopy; a significant number of lymphocytes showed lamellated inclusions indicating lipidosis. In a subchronic experiment (7 weeks) female rats received 140 mg/kg per day, and several organs were examined. Marked lipidosis-like alterations were found in lymph node, adrenal cortex and medulla, kidney, lung and in a sympathetic ganglion. Mild lysosomal alterations were found in hepatocytes and retinal pigment epithelium. Lipidosis was very weak, or absent, in retinal ganglion cells, trigeminal ganglion cells and in hypothalamic neurosecretory perikarya. In addition, citalopram produced myopathic alterations in soleus muscle resembling those previously induced with other cationic amphiphilic drugs. Myopathy persisted during a drug-free recovery period of 4 weeks, whereas generalized lipidosis was reversible within 2-4 weeks. The present results support a previously proposed concept concerning the structure-response relationships underlying drug-induced lipidosis.

[1]  P. Kragh‐Sørensen,et al.  The kinetics of citalopram: single and multiple dose studies in man. , 2009, Acta pharmacologica et toxicologica.

[2]  R. Lüllmann-Rauch,et al.  Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses. , 1981, Toxicology and applied pharmacology.

[3]  Y. Matsuzawa,et al.  Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. , 1981, Biochemical pharmacology.

[4]  R. Lüllmann-Rauch,et al.  Zimelidine-induced lipidosis in rats. , 2009, Acta pharmacologica et toxicologica.

[5]  H. Lüllmann,et al.  Ca replacement by cationic amphiphilic drugs from lipid monolayers. , 1980, Biochemical pharmacology.

[6]  M. Wehling,et al.  The binding of drugs to different polar lipids in vitro. , 1979, Biochemical pharmacology.

[7]  R. Lüllmann-Rauch,et al.  Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs , 1979, Neuroscience.

[8]  R. Lüllmann-Rauch,et al.  Lipidosis induced by amphiphilic cationic drugs. , 1978, Biochemical pharmacology.

[9]  O. Svendsen,et al.  Hepatotoxicity of citalopram in rats and first-pass metabolism. , 1978, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[10]  O. Svendsen,et al.  Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. , 1977, European journal of pharmacology.

[11]  R. Lüllmann-Rauch,et al.  Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. , 1976, Laboratory investigation; a journal of technical methods and pathology.

[12]  R. Lüllmann-Rauch Lipidosislike renal changes in rats treated with chlorphentermine or with tricyclic antidepressants , 1975, Virchows Archiv. B, Cell pathology.

[13]  R. Lüllmann-Rauch Chlorphentermine-induced abnormal cytoplasmic inclusions in peripheral blood cells of rats and guinea pigs , 1975 .

[14]  J. Ledingham,et al.  Intensification of osmium staining by p-phenylenediamine: paraffin and epon embedding; lipid granules in renal medulla. , 1970, Stain technology.